Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268174 · ClinicalTrials.gov registry record · NA
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
A NA study of Atopic Dermatitis Eczema, sponsored by AOBiome.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03268174 is a NA study of Atopic Dermatitis Eczema that has completed, run by AOBiome. The registered enrollment target is 19 participants, below the 199-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03268174, a NA study of Atopic Dermatitis Eczema, has completed, sponsored by AOBiome.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe the performance of a cosmetic product, AO+Mist, on the appearance of arm skin in subjects with atopic dermatitis
Conditions Studied
Interventions
- OTHER Placebo
- OTHER AO+Mist
Study Locations (1)
Illinois
- Medical Dermatology Associates of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-05-11 |
| Est. Completion | 2017-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268174
The ClinicalTrials.gov registry entry for NCT03268174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 199-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (90% lower). The listed sponsor is AOBiome, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atopic Dermatitis Eczema appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03268174 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03268174 about?
NCT03268174 is a clinical study titled "Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.". The purpose of this study is to observe the performance of a cosmetic product, AO+Mist, on the appearance of arm skin in subjects with atopic dermatitis
What is the current status of trial NCT03268174?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-05-11. Estimated completion is 2017-02-13.
What conditions does trial NCT03268174 study?
This clinical trial studies the following conditions: Atopic Dermatitis Eczema.
What interventions are being tested in trial NCT03268174?
The interventions under investigation include: Placebo (OTHER), AO+Mist (OTHER).
Who is sponsoring clinical trial NCT03268174?
This trial is sponsored by AOBiome, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03268174 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis Eczema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
-
Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema
COMPLETED · NA
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
RECRUITING · Phase 2
-
Seal, Stopping Eczema and Allergy Study
ACTIVE NOT RECRUITING · Phase 2
-
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.